CNV — Cnova NV Income Statement
0.000.00%
Last trade - 00:00
- €1.52bn
- €2.57bn
- €1.20bn
- 32
- 34
- 35
- 22
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,194 | 2,225 | 2,162 | 1,700 | 1,197 |
Cost of Revenue | |||||
Gross Profit | 389 | 474 | 474 | 394 | 362 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,196 | 2,184 | 2,156 | 1,751 | 1,236 |
Operating Profit | -1.87 | 40.8 | 6.29 | -50.3 | -39.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -58.5 | -13.2 | -46.5 | -123 | -97.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -61.6 | -15.6 | -51.3 | -128 | -126 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -66.1 | -23.4 | -51.1 | -126 | -126 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -66.1 | -23.4 | -51.1 | -126 | -126 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.15 | -0.028 | -0.14 | -0.363 | -0.306 |
Dividends per Share |